Praxis Precision Medicines, Inc. (PRAX)
368.03
-7.91
(-2.10%)
USD |
NASDAQ |
Aug 24, 16:00
363.03
-5.00
(-1.36%)
After-Hours: 05:17
Praxis Precision Medicines Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2024 | 99.37% |
| September 30, 2024 | 69.54% |
| June 30, 2024 | 70.03% |
| March 31, 2024 | 74.01% |
| Date | Value |
|---|---|
| December 31, 2023 | 78.45% |
| September 30, 2023 | 31.41% |
| June 30, 2023 | 60.05% |
| March 31, 2023 | 55.05% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | 69.28% |
| Insmed, Inc. | 83.71% |
| Ionis Pharmaceuticals, Inc. | 96.13% |
| Perspective Therapeutics, Inc. | -1.31K% |
| Regeneron Pharmaceuticals, Inc. | 83.68% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -38.74% |
| Return on Assets | -36.56% |
| Return on Invested Capital | -38.71% |
| Return on Net Operating Assets | -31.31K% |